We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+2.16%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$34.7B
AUM Growth
+$242M
(+0.7%)
Cap. Flow
-$120M
Cap. Flow
% of AUM
-0.35%
Top 10 Holdings %
Top 10 Hldgs %
14.95%
Holding
3,089
New
65
Increased
2,336
Reduced
597
Closed
54
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$47.6M |
| 2 |
Medtronic
MDT
|
+$41.4M |
| 3 |
SLB Ltd
SLB
|
+$25M |
| 4 |
American Airlines Group
AAL
|
+$19.2M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$18.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan Inc
AGN
|
+$107M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$68.5M |
| 3 |
Apple
AAPL
|
+$22.9M |
| 4 |
CFN
CAREFUSION CORPORATION
CFN
|
+$16.9M |
| 5 |
PETM
PETSMART INC
PETM
|
+$14M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.74% |
| 2 | Financials | 14.67% |
| 3 | Healthcare | 14.62% |
| 4 | Industrials | 10.93% |
| 5 | Consumer Discretionary | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SLXP
351
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $17M | 0.05% |
98,339
+7,810
| +9% | +$1.15M |
|
352
iShares Russell 1000 ETF
IWB
$49B
| $16.8M | 0.05% |
145,079
+72,675
| +100% | +$8.39M |
|
353
Advance Auto Parts
AAP
$3.36B
| $16.8M | 0.05% |
112,244
+10,241
| +10% | +$1.58M |
|
354
BioMarin Pharmaceuticals
BMRN
$11.6B
| $16.8M | 0.05% |
134,544
+9,836
| +8% | +$1.04M |
|
355
McCormick & Company Non-Voting
MKC
$13.9B
| $16.6M | 0.05% |
430,744
-4,106
| -0.9% | -$152K |
|
356
J.M. Smucker
SJM
$12.6B
| $16.6M | 0.05% |
143,099
+10,487
| +8% | +$1.15M |
|
357
Royal Caribbean
RCL
$86.7B
| $16.4M | 0.05% |
200,891
+13,180
| +7% | +$1.04M |
|
358
Regions Financial
RF
$26.9B
| $16.4M | 0.05% |
1,738,907
-20,049
| -1% | -$190K |
|
|
ANDV
359
DELISTED
Andeavor
ANDV
| $16.4M | 0.05% |
179,319
-19,915
| -10% | -$1.67M |
|
360
Realty Income
O
$59.2B
| $16.4M | 0.05% |
327,239
+32,415
| +11% | +$1.62M |
|
|
CA
361
DELISTED
CA, Inc.
CA
| $16.3M | 0.05% |
500,468
-18,210
| -4% | -$577K |
|
362
Aptiv
APTV
$12.1B
| $16.3M | 0.05% |
204,325
-7,410
| -3% | -$557K |
|
363
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.7B
| $16.3M | 0.05% |
+58,655
| New | +$15.8M |
|
364
Agilent Technologies
A
$39.5B
| $16.3M | 0.05% |
391,297
-3,610
| -0.9% | -$146K |
|
|
PLL
365
DELISTED
PALL CORP
PLL
| $16.2M | 0.05% |
161,286
+1,438
| +0.9% | +$145K |
|
366
Signet Jewelers
SIG
$3.69B
| $16.2M | 0.05% |
116,510
+10,844
| +10% | +$1.34M |
|
367
Macerich
MAC
$7.34B
| $16.1M | 0.05% |
191,081
-880
| -0.5% | -$77K |
|
368
Pentair
PNR
$10.7B
| $16M | 0.05% |
377,657
-10,640
| -3% | -$463K |
|
369
KeyCorp
KEY
$24.5B
| $15.9M | 0.05% |
1,125,124
-20,714
| -2% | -$285K |
|
370
Travel + Leisure Co
TNL
$4.72B
| $15.7M | 0.05% |
385,483
-30,277
| -7% | -$1.21M |
|
371
CBRE Group
CBRE
$43B
| $15.6M | 0.05% |
404,079
+1,970
| +0.5% | +$67.9K |
|
372
Cheniere Energy
LNG
$54.1B
| $15.6M | 0.04% |
201,152
+5,550
| +3% | +$414K |
|
373
Polaris
PII
$4.02B
| $15.6M | 0.04% |
110,217
+10,310
| +10% | +$1.52M |
|
374
Coca-Cola Europacific Partners
CCEP
$47.8B
| $15.5M | 0.04% |
350,793
-1,599
| -0.5% | -$69.8K |
|
|
KSU
375
DELISTED
Kansas City Southern
KSU
| $15.5M | 0.04% |
151,836
-936
| -0.6% | -$106K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2015 Portfolio in Review
As of Q1 2015, RhumbLine Advisers held 3,089 positions worth $34.7B, up 0.7% from $34.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Trading was light in Q1 2015: portfolio turnover was 3.9%. RhumbLine Advisers opened 65 new positions and exited 54, leaving the 3,089-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2015 buy was Qorvo: 254,331 shares worth $20.3M.
- RhumbLine Advisers added most to Allergan plc in Q1 2015, an estimated $47.6M increase.
- RhumbLine Advisers's biggest Q1 2015 reduction was Apple, cutting an estimated $22.9M.
- RhumbLine Advisers fully exited Allergan Inc in Q1 2015, selling an estimated $107M.
- RhumbLine Advisers's ten largest holdings make up 15% of its $34.7B portfolio in Q1 2015.
- RhumbLine Advisers opened 65 new positions and closed 54 in Q1 2015.
- RhumbLine Advisers's portfolio value rose 0.7% quarter-over-quarter to $34.7B.
Based on RhumbLine Advisers's 13F filing for Q1 2015, filed 12 May 2015.